SPOTLIGHT -
EP. 1: Breast Cancer: Genomic Testing for Adjuvant Therapy
EP. 2: MINDACT Trial Design and Results in Breast Cancer
EP. 3: Breast Cancer: Genomic Testing
EP. 4: Comparison of Prognostic Tests in Breast Cancer
EP. 5: Breast Cancer: Extended Adjuvant Endocrine Therapy
EP. 6: FALCON Trial Data in HR+ Metastatic Breast Cancer
EP. 7: Ribociclib for HR+ Advanced Breast Cancer
EP. 8: Emerging Role of Abemaciclib for HR+ Advanced Breast Cancer
EP. 9: Everolimus for HR+ Metastatic Breast Cancer
EP. 10: PI3K Inhibitors in HR+ Metastatic Breast Cancer
EP. 11: HER2-Targeted Therapy in Early Stage HER2+ Breast Cancer
EP. 12: Extended Adjuvant Therapy for HER2+ Early Breast Cancer
EP. 13: Treating HER2+ Metastatic Breast Cancer
EP. 14: BRCA1/2 Status and Homologous Repair Deficiency in TNBC
EP. 15: Immunotherapy for TNBC
EP. 16: Antibody-Drug Conjugates for TNBC
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
